Companies / Acrivon Therapeutics
Acrivon Therapeutics
Greater Boston, United States
Acrivon is developing targeted therapies to improve the lives of patients.
Acrivon Therapeutics, based in Greater Boston, United States, has 3 investors on file, among them NEA, Pureos Bioventures and RA Capital. Its site was last checked 13 Nov 2026: site answers.
Investors
3 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
In the news
2 headlines naming Acrivon TherapeuticsEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Acrivon Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when NEA adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/acrivon.com/investors
# also
GET /v1/companies/acrivon.com
GET /v1/companies/acrivon.com/news